Banner
What Next For Messenger RNA (mRNA)? Maybe Inhalable Vaccines

No one likes getting a needle but most want a vaccine. A new paper shows progress for messenger...

Toward A Single Dose Smallpox And Mpox Vaccine With No Side Effects

Attorney Robert F. Kennedy Jr. and his US followers over the last 25 years have staunchly opposed...

ChatGPT Is Cheaper In Medicine And Does Better Diagnoses Even Than Doctors Using ChatGPT

General medicine, routine visits and such, have gradually gone from M.D.s to including Osteopaths...

Even After Getting Cancer, Quitting Cigarettes Leads To Greater Longevity

Cigarettes are the top lifestyle risk factor for getting cancer, though alcohol and obesity have...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll

The legalization of recreational marijuana in Colorado was associated with both increased hospital visits and cases at a regional poison center because of unintentional exposure to the drug by children, suggesting effective preventive measures are needed as more states consider legalizing the drug, according to an article published online by JAMA Pediatrics.

More than half of U.S. states allowed medical marijuana and four states allowed recreational marijuana use as of 2015. Colorado is one of those states, having allowed medical marijuana in 2000 and recreational marijuana becoming available for purchase in 2014.

Does a long travel time to a primary stroke center (PSC) offset the potential benefits of this specialized care?

In an article published online by JAMA Internal Medicine, Kimon Bekelis, M.D., of Dartmouth-Hitchcock Medical Center, Lebanon, N.H., and coauthors analyzed data for a national group of Medicare beneficiaries and calculated travel time to evaluate the association of seven-day and 30-day death rates with receiving care in a PSC.

Stroke is a leading cause of death and long-term disability in the United States. To maximize patient outcomes, referral centers - PSCs certified by The Joint Commission are the backbone of this - have been established to ensure adherence to guidelines and the efficient delivery of disease-specific care.

Osteopaths have made their way into various aspects of medicine, primarily because they are still willing to be GPs at a time when MDs are running from government bureaucracy and paperwork, but their founding precepts are still vague. And if you want vague treatment, it is best to find vague conditions. There is no more vague condition than pain.

Since the early 1900s, a subset of wealthy elites with a Malthusian mindset have been convinced that the world is overpopulated. Rather than let poor people starve, as British policy in the home of Malthus advocated, later generations sought to breed out the poor with eugenics, and forced sterilization. After World War II made eugenics wildly unpopular, proponents reframed their ideas as "population control." Groups like Planned Parenthood, Sierra Club and Environmental Defense Fund were all founded by former eugenics advocates. Their supporters, like Paul Ehrlich and John Holdren, also advocated forced sterilization and abortion, to limit population. 

From recycling to reusing hotel towels, consumers who participate in a company's "green" program are more satisfied with its service, finds a new study co-led by a Michigan State University researcher.

Doing good makes customers feel good, and that "warm glow" shapes opinion, said Tomas Hult, Byington Endowed Chair and professor of marketing in the Eli Broad College of Business. But it gets more complicated when companies throw incentives into the mix.

PHILADELPHIA -- In the era of precision medicine, targeting the mutations driving cancer growth, rather than the tumor site itself, continues to be a successful approach for some patients. In the latest example, researchers from Penn Medicine and other institutions found that treating metastatic thyroid cancer patients harboring a BRAF mutation with the targeted therapy vemurafenib -- originally approved for melanoma patients with the mutation -- showed promising anti-tumor activity in a third of patients. The results were published in this week's Lancet Oncology.